<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.02">
 <iati-activity default-currency="CAD" hierarchy="1" iati-activities:version="2.02" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>XM-DAC-301-2-109303-001</iati-identifier>
  <reporting-org ref="XM-DAC-301-2" type="15">
   <narrative xml:lang="FR">Centre de recherches pour le d&#xE9;veloppement international</narrative>
   <narrative xml:lang="ES">Centro Internacional de Investigaciones para el Desarrollo</narrative>
   <narrative xml:lang="EN">International Development Research Centre</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="FR">Am&#xE9;liorer les outils pour assurer une surveillance compl&#xE8;te de la r&#xE9;sistance aux antimicrobiens chez l&#x2019;homme et dans l&#x2019;environnement</narrative>
   <narrative xml:lang="EN">Improving tools to enable comprehensive surveillance of antimicrobial resistance in humans, animals and the environment</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="EN">A number of countries and international organizations have stressed the need for integrated surveillance systems to comprehensively detect and monitor antimicrobial resistance (AMR), particularly in animal and environmental reservoirs. The World Health Organization has responded with the development of the &#x201C;Tricycle Protocol&#x201D;, a basic protocol for the surveillance of antibiotic-resistant E. coli in healthy human populations (pregnant women), infected patients (bloodstream infections), in the animal sector (focusing on poultry), and in natural environments (targeting raw human and animal wastewater and surface water).

This project aims to strengthen the Tricycle Protocol by expanding the scope of AMR surveillance to include additional bacterial strains of significant public health concern. The project also proposes to integrate whole-genome sequencing technologies into the Tricycle Protocol. Doing so will greatly strengthen the epidemiological power of this surveillance system and allow for faster and more effective detection, investigation, and tracking of antimicrobial resistant bacteria. 

This is one of five IDRC-funded projects developed through the Joint Programming Initiative on Antimicrobial Resistance (JPIAMR), an international platform that coordinates global funding to support collaborative research and action on antimicrobial resistance. Through the JPIAMR, IDRC has partnered with 18 other donor agencies to fund innovative research on diagnostics and surveillance strategies, tools, and technologies that can be used to detect and monitor antimicrobial resistance in human, animal, and environmental settings, particularly in low and middle-income countries.</narrative>
   <narrative xml:lang="FR">Un certain nombre de pays et d&#x2019;organisations internationales ont soulign&#xE9; la n&#xE9;cessit&#xE9; de mettre en place des syst&#xE8;mes de surveillance int&#xE9;gr&#xE9;s pour d&#xE9;tecter et surveiller de mani&#xE8;re exhaustive la RAM, en particulier dans les r&#xE9;servoirs animaux et environnementaux. L&#x2019;Organisation mondiale de la sant&#xE9; a r&#xE9;agi en &#xE9;laborant le &#xAB; protocole tricycle &#xBB;, qui est un protocole de base pour la surveillance des E. coli r&#xE9;sistants aux antibiotiques dans les populations humaines en bonne sant&#xE9; (femmes enceintes), les patients infect&#xE9;s (infections du sang), le secteur animal (en se concentrant sur la volaille), et les environnements naturels (en ciblant les eaux us&#xE9;es et les eaux de surface brutes humaines et animales).

Ce projet vise &#xE0; renforcer le protocole tricycle en &#xE9;largissant la port&#xE9;e de la surveillance de la RAM, afin d&#x2019;inclure d&#x2019;autres souches bact&#xE9;riennes pr&#xE9;sentant un risque important pour la sant&#xE9; publique. De plus, le projet propose d&#x2019;int&#xE9;grer les technologies de s&#xE9;quen&#xE7;age du g&#xE9;nome entier dans le protocole tricycle. Cela renforcera consid&#xE9;rablement le pouvoir &#xE9;pid&#xE9;miologique de ce syst&#xE8;me de surveillance et permettra d&#x2019;effectuer une d&#xE9;tection, une &#xE9;tude et un suivi plus rapides et plus efficaces des bact&#xE9;ries r&#xE9;sistantes aux antimicrobiens. 

Il s&#x2019;agit de l&#x2019;un des cinq projets financ&#xE9;s par le CRDI qui ont &#xE9;t&#xE9; &#xE9;labor&#xE9;s dans le cadre de Joint Programming Initiative on Antimicrobial Resistance (JPIAMR), une plateforme internationale qui coordonne le financement mondial pour appuyer la recherche et l&#x2019;action concert&#xE9;es sur la r&#xE9;sistance aux antimicrobiens. Par l&#x2019;interm&#xE9;diaire du JPIAMR, le CRDI s&#x2019;est associ&#xE9; &#xE0; 18 autres organismes donateurs pour financer des recherches novatrices sur les strat&#xE9;gies, les outils et les technologies de diagnostic et de surveillance pouvant servir &#xE0; la d&#xE9;tection et au suivi de la r&#xE9;sistance aux antimicrobiens chez les humains, les animaux et dans l&#x2019;environnement, en particulier dans les pays &#xE0; revenu faible et &#xE0; revenu interm&#xE9;diaire.</narrative>
  </description>
  <participating-org role="1" type="10">
   <narrative xml:lang="FR">Canada. Parlement</narrative>
   <narrative xml:lang="EN">Canada. Parliament</narrative>
  </participating-org>
  <participating-org role="2" type="22">
   <narrative xml:lang="EN">Clinical Research Malaysia</narrative>
  </participating-org>
  <participating-org role="4" type="22">
   <narrative xml:lang="MS">Institiut Penyelidikan Perubatan</narrative>
   <narrative xml:lang="EN">Institute for Medical Research</narrative>
  </participating-org>
  <participating-org role="3" type="15">
   <narrative xml:lang="FR">Centre de recherches pour le d&#xE9;veloppement international</narrative>
   <narrative xml:lang="ES">Centro Internacional de Investigaciones para el Desarrollo</narrative>
   <narrative xml:lang="EN">International Development Research Centre</narrative>
  </participating-org>
  <activity-status code="2"></activity-status>
  <activity-date iso-date="2020-10-01" type="2"></activity-date>
  <activity-date iso-date="2023-10-01" type="3"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="FR">Centre de recherches pour le d&#xE9;veloppement international</narrative>
    <narrative xml:lang="EN">International Development Research Centre</narrative>
   </organisation>
   <telephone>(+1) 613-236-6163</telephone>
   <email>info@idrc.ca</email>
   <website>http://www.idrc.ca</website>
   <mailing-address>
    <narrative xml:lang="FR">CP 8500, Ottawa ON Canada, K1G 3H9</narrative>
    <narrative xml:lang="EN">PO Box 8500, Ottawa ON Canada, K1G 3H9</narrative>
   </mailing-address>
  </contact-info>
  <activity-scope code="1"></activity-scope>
  <recipient-country code="MG" percentage="25"></recipient-country>
  <recipient-country code="MY" percentage="25"></recipient-country>
  <recipient-country code="PK" percentage="25"></recipient-country>
  <recipient-region code="998" percentage="25" vocabulary="1"></recipient-region>
  <sector code="1" percentage="100" vocabulary="99">
   <narrative xml:lang="FR">Autre</narrative>
   <narrative xml:lang="EN">Other</narrative>
  </sector>
  <sector code="12182" percentage="100" vocabulary="1"></sector>
  <policy-marker code="1" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="2" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="3" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="4" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="5" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="6" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="7" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="8" significance="0" vocabulary="1"></policy-marker>
  <policy-marker code="9" significance="0" vocabulary="1"></policy-marker>
  <collaboration-type code="1"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-10-02"></transaction-date>
   <value currency="CAD" value-date="2020-10-02">263400</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="MS">Institiut Penyelidikan Perubatan</narrative>
    <narrative xml:lang="EN">Institute for Medical Research</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2020-10-07"></transaction-date>
   <value currency="CAD" value-date="2020-10-07">36650</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="MS">Institiut Penyelidikan Perubatan</narrative>
    <narrative xml:lang="EN">Institute for Medical Research</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2020-10-31"></transaction-date>
   <value currency="CAD" value-date="2020-10-31">-36650</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="MS">Institiut Penyelidikan Perubatan</narrative>
    <narrative xml:lang="EN">Institute for Medical Research</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2020-10-31"></transaction-date>
   <value currency="CAD" value-date="2020-10-31">36650</value>
   <provider-org>
    <narrative xml:lang="FR">Canada. Parlement</narrative>
    <narrative xml:lang="EN">Canada. Parliament</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="MS">Institiut Penyelidikan Perubatan</narrative>
    <narrative xml:lang="EN">Institute for Medical Research</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <conditions attached="1">
   <condition type="2">
    <narrative xml:lang="EN">Grant is conditional on completion of specified terms of reference, receipt of specified deliverables</narrative>
    <narrative xml:lang="FR">La bourse est octroy&#xE9;e &#xE0; condition de respecter le mandat &#xE9;tabli et de livrer les r&#xE9;sultats attendus</narrative>
   </condition>
   <condition type="3">
    <narrative xml:lang="EN">Grant is conditional on periodic submission of a detailed accounting of expenditure of funds received from IDRC accompanied by estimation of budget for the next reporting period</narrative>
    <narrative xml:lang="FR">La bourse est octroy&#xE9;e &#xE0; condition de p&#xE9;riodiquement pr&#xE9;senter une justification d&#xE9;taill&#xE9;e de l&apos;utilisation des fonds vers&#xE9;s par le CRDI ainsi qu&apos;une estimation budg&#xE9;taire de la p&#xE9;riode de rapport suivante</narrative>
   </condition>
  </conditions>
 </iati-activity>
</iati-activities>
